AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 117 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $854,000 | +97.7% | 56,433 | -2.0% | 0.00% | 0.0% |
| Q2 2022 | $432,000 | -15.3% | 57,612 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $510,000 | +19.2% | 56,095 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $428,000 | -36.8% | 60,939 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $677,000 | -27.6% | 59,405 | +1.7% | 0.00% | 0.0% |
| Q2 2021 | $935,000 | -5.5% | 58,406 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $989,000 | +32.2% | 55,344 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | +14.9% | 55,344 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $651,000 | -20.2% | 55,344 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $816,000 | -5.2% | 55,311 | -13.2% | 0.00% | -50.0% |
| Q1 2020 | $861,000 | -44.7% | 63,756 | -1.1% | 0.00% | -33.3% |
| Q4 2019 | $1,558,000 | +23.3% | 64,475 | -2.0% | 0.00% | +50.0% |
| Q3 2019 | $1,264,000 | -34.2% | 65,778 | +1.2% | 0.00% | -50.0% |
| Q2 2019 | $1,921,000 | -25.7% | 64,992 | +19.3% | 0.00% | -20.0% |
| Q1 2019 | $2,587,000 | +28.7% | 54,467 | -2.2% | 0.01% | 0.0% |
| Q4 2018 | $2,010,000 | -40.0% | 55,678 | +2.3% | 0.01% | -28.6% |
| Q3 2018 | $3,350,000 | -8.9% | 54,423 | -0.0% | 0.01% | -12.5% |
| Q2 2018 | $3,678,000 | +30.8% | 54,442 | +5.0% | 0.01% | +33.3% |
| Q1 2018 | $2,812,000 | -9.9% | 51,826 | -0.8% | 0.01% | 0.0% |
| Q4 2017 | $3,121,000 | +22.2% | 52,235 | -0.6% | 0.01% | 0.0% |
| Q3 2017 | $2,553,000 | -9.7% | 52,525 | -2.4% | 0.01% | 0.0% |
| Q2 2017 | $2,827,000 | +9.7% | 53,795 | -5.3% | 0.01% | +20.0% |
| Q1 2017 | $2,576,000 | +14.6% | 56,802 | -4.4% | 0.01% | 0.0% |
| Q4 2016 | $2,248,000 | +16.8% | 59,402 | +16.5% | 0.01% | +25.0% |
| Q3 2016 | $1,925,000 | +116.5% | 51,002 | +1.0% | 0.00% | +100.0% |
| Q2 2016 | $889,000 | +66.8% | 50,502 | +15.3% | 0.00% | +100.0% |
| Q1 2016 | $533,000 | -42.3% | 43,817 | +15.4% | 0.00% | -50.0% |
| Q4 2015 | $924,000 | +39.4% | 37,966 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $663,000 | +0.3% | 37,366 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $661,000 | +9.3% | 37,466 | +94.2% | 0.00% | +100.0% |
| Q1 2015 | $605,000 | +6.3% | 19,293 | -1.0% | 0.00% | 0.0% |
| Q4 2014 | $569,000 | +41.5% | 19,493 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $402,000 | -15.5% | 19,410 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $476,000 | +60.3% | 19,200 | +37.1% | 0.00% | 0.0% |
| Q1 2014 | $297,000 | +18.3% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $251,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |